We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 66,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/8/2020 08:22 | precursor to a cash raise ?? | buywell3 | |
11/8/2020 08:21 | Same here. 👉🏾 | rayrac | |
11/8/2020 08:20 | Off out. No ranc, no point | kreature | |
11/8/2020 08:13 | Great rns, building very nicely indeed | robo28 | |
11/8/2020 08:13 | Maybe extend that into flatulence disorders ? | kreature | |
11/8/2020 08:07 | “The Company has been awarded (subject to contract) a grant to explore the effect of LP(LDL) (R) on stress, anxiety, and sleep disorders with Universities in the UK and Europe“ The directors taking advantage of this effect?...could help? Subject to contract of course | rayrac | |
11/8/2020 07:59 | no financials in commercial update? as ranc as ever. Hence think I will delay buying shares today | kreature | |
11/8/2020 07:51 | for disappointment | kreature | |
11/8/2020 07:50 | H2 recognised revenues expected to be far greater than H1, so massive potential. | kreature | |
11/8/2020 07:50 | Ooooh..never that surely? Rumbled? | rayrac | |
11/8/2020 07:47 | On the basis of a lack of money ? lack of profit ? | kreature | |
11/8/2020 07:45 | :)) on what basis? Lack of potential? | rayrac | |
11/8/2020 07:39 | Doubt it though. Would it be prudent to raise some more cash at this point, at least enough to fund the interviews and RNS releases ? | kreature | |
11/8/2020 07:34 | Probably just phase 1 ? | kreature | |
11/8/2020 07:32 | creates the potential for LPLDL® to be commercialised as a pharmaceutical drug product’ They putting it through phase 1/2/3 trials then? | rayrac | |
11/8/2020 07:30 | Lol! Never thought of that! | rayrac | |
11/8/2020 07:29 | ‘ creates the potential for LPLDL® to be commercialised as a pharmaceutical drug product’ Amazeballs. ....and creates the potential for a second wave placing ? | kreature |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions